Expression of CD44v6 and its prognostic significance in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 8, Issue 3, 2005, Pages 215-218

  Wu, Qiuping ^a   Jiang, Yaoguang ^a   Min, Jiaxin ^a   Xiang, Mingzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD44v6; Non small cell lung cancer

Indexed keywords

CD44V6 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 21844465442     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest, 1993, 68(1): 4-17.
2. Yamamichi K, Uehara Y, Kitamura N, et al. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Int J Cancer, 1998, 79(3): 256-262.
3. Zhou QH, Wang H. The key points and direction of basic research on lung cancer of the 21th century in China. Chin J Lung Cancer, 2000, 3(1): 5-7. 2000, 3(1): 5-7.
4. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res, 1994, 54(14): 3922-3928.
5. Tarin D, Matsumura Y. Deranged CD44 gene activity in malignancy. J Pathol, 1993, 171(4): 249-250.
6. Tran TA, Kallakury BV, Sheehan CE, et al. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Hum Pathol, 1997, 28(7): 809-814.
7. Guo YJ, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res, 1994, 54(2): 422-426.
8. Nguyen VN, Mirejovsky T, Melinova L, et al. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma, 2000, 47(6): 400-408.